Földi E
Foldiklinik Fachklinik für Lymphologie, Hinterzarten, Germany.
Cancer. 1998 Dec 15;83(12 Suppl American):2833-4. doi: 10.1002/(sici)1097-0142(19981215)83:12b+<2833::aid-cncr35>3.0.co;2-3.
Before the treatment of arm lymphedema after breast carcinoma treatment with complex decongestive physiotherapy can be initiated, it is mandatory to differentiate between benign and malignant forms (due to relapse) and to establish the diagnosis of accompanying diseases, if present.
In benign lymphedemas, the aim of complex decongestive physiotherapy is to restore the symptom free "Stage 0 of latency" and to maintain fitness for work. The palliative treatment of malignant lymphedemas results in the amelioration of the quality of life.
The results of treatment depend on the experience of the physician in clinical lymphology, on the training and dedication of the lymphedema therapist, and on the compliance of the patient.
A study concerning gene expression has shown that complex decongestive physiotherapy influences the pathological alterations of the interstitium in lymphedema patients.
在用综合消肿物理疗法治疗乳腺癌治疗后的手臂淋巴水肿之前，必须区分良性和恶性形式（由于复发），并确定是否存在伴随疾病的诊断。
在良性淋巴水肿中，综合消肿物理疗法的目的是恢复无症状的“潜伏期0期”并保持工作能力。恶性淋巴水肿的姑息治疗可改善生活质量。
治疗结果取决于医生在临床淋巴学方面的经验、淋巴水肿治疗师的培训和奉献精神以及患者的依从性。
一项关于基因表达的研究表明，综合消肿物理疗法会影响淋巴水肿患者间质的病理改变。
